DUBLIN, Ohio, April 22, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024 ...

Cardinal Health employs 48,000 and posted sales of $205 billion in 2023. The firm serves almost 90 percent of U.S. hospitals, more than 60,000 U.S. pharmacies and more than 10,000 specialty ...

Getty Images Cardinal Health said its contracts with the pharmacy benefits provider of UnitedHealth Group, OptumRX, won't be renewed, and shares fell in intraday trading Monday. The health insurer ...

(Reuters) - Cardinal Health said on Monday its contracts with UnitedHealth Group's OptumRx, one of its largest customers, will not be renewed after they expire at the end of June, sending the drug ...

The U.S. Food and Drug Administration (FDA) has warned the medical distributor Cardinal Health (NYSE:CAH) for marketing unauthorized syringes, according to a safety update from the regulator on ...

Cardinal Health (NYSE:CAH) shares fell 5% on Monday after the company said its pharmaceutical distribution contracts with UnitedHealth Group’s (NYSE:UNH) OptumRx unit will not be renewed ...

Cardinal Health (CAH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Cardinal Health Inc.’s stock fell 4% early Monday, after the drug distributor and medical-laboratory products maker said its contracts with pharmacy-benefits manager OptumRx will expire at the ...

Wells Fargo analyst Steve Baxter maintained a Sell rating on Cardinal Health (CAH – Research Report) yesterday and set a price target of $94.00. Steve Baxter has given his Sell rating due to a ...

Cardinal Health expects to partially offset the impact of OptumRx through new customer wins, specialty growth, and other actions. Sales to OptumRx generated 16% of Cardinal Health's consolidated ...